MABPROTEIN
mAbProtein is a research and develop, manufacture, and sell research reagents, diagnostics, and pharmaceuticals that utilize the research seeds (special antibody production technology) of Prof.
MABPROTEIN
Industry:
3D Printing Industrial Manufacturing Wood Processing
Founded:
2018-03-20
Address:
Izumo, Shimane, Japan
Country:
Japan
Website Url:
http://www.mabprotein.co.jp
Total Employee:
1+
Status:
Active
Contact:
0853-27-9950
Email Addresses:
[email protected]
Total Funding:
150 M JPY
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Buildink
Buildink is disrupting the construction industry with concrete 3D printing technology enabling the delivery of homes in less than one week.
Orange Maker
Orange Maker is a 3d printing technology company that develops solutions for advanced 3D printing systems and creates software programs.
Current Employees Featured
Investors List
San-in Godo Bank
San-in Godo Bank investment in Seed Round - mAbProtein
REVIC
REVIC investment in Seed Round - mAbProtein
Gogin Capital
Gogin Capital investment in Seed Round - mAbProtein
Official Site Inspections
http://www.mabprotein.co.jp
- Host name: sv7071.xserver.jp
- IP address: 183.181.97.72
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
More informations about "mAbProtein"
マブプロテイン｜抗体製造 mAbProtein | 島根大学発のバイオベン …
MAbProtein 社は島根大学医学部の浦野健（うらの たけし）教授の研究シーズ（特殊な抗体作製技術）を活用した研究試薬・診断薬・医薬の研究開発及び製造販売を目的として設立された …See details»
mAbProtein - Crunchbase Company Profile & Funding
Where is mAbProtein's headquarters? mAbProtein is located in Izumo, Shimane, Japan. Who invested in mAbProtein? mAbProtein has 3 investors including …See details»
mAbProtein Company Profile 2024: Valuation, Funding & Investors …
Operator of a bio-venture firm intended to develop therapeutic antibodies that meet unmet medical needs in inflammatory diseases.See details»
株式会社mAbProtein | カンファレンスパーク
MAbProtein社は島根大学医学部の浦野 健 教授の技術シーズ（独自抗体作製技術）を活用した研究試薬・診断薬・医薬の研究開発及び製造販売を目的として設立された大学発のバイオベン …See details»
株式会社mAbProteinの会社情報と資金調達 | NIKKEI COMPASS
【NIKKEI COMPASS】株式会社mAbProteinは、島根大学医学部・浦野健教授による独自の抗体作製技術を活用し、研究試薬・診断薬・医薬の研究開発や製造販売を行うバイオベンチャー …See details»
MABPROTEIN, K.K. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for MABPROTEIN, K.K. of IZUMO, SHIMANE. Get the latest business insights from Dun & …See details»
株式会社mAbProtein | InfoBase
株式会社mAbProtein. 会社概要. 抗体作製技術を活用した医薬品開発を手掛ける島根大学発スタートアップです。抗体を用いた研究試薬や診断キットなどの開発・製造・販売、抗体を用い …See details»
MAbProtein Co., Ltd. - CMOCRO
MAbProtein was established for the research and development of research reagents, diagnostics, and pharmaceuticals utilizing the research seeds and also established to help patients, …See details»
mAbProtein Co. Ltd. - Drug pipelines, Patents, Clinical trials
Explore mAbProtein Co. Ltd. with its drug pipeline, therapeutic area, technology platform, 5 literature.See details»
島根大学発バイオベンチャー「株式会社mAbProtein」を設立し、 …
Jul 5, 2018 · 株式会社mAbProteinは、医学部生化学講座（病態生化学）の浦野 健 教授の研究シーズを活用した『抗体』を用いて、医薬・診断薬・研究試薬の研究開発及び製造販売などの …See details»
mAbProtein - VentureRadar
Website: https://mabprotein.co.jp/ mAbProtein originated from Shimane University for the purpose of research and development, manufacturing and sales of research reagents, diagnostic …See details»
株式会社mAbProtein｜スピーダ スタートアップ情報リサーチ
May 30, 2018 · 抗体作製技術を活用した医薬品開発を手掛ける島根大学発スタートアップ。 抗体を用いた研究試薬や診断キット等の開発・製造・販売。 抗体を用いた分析検査サービス及 …See details»
mAbProteinと難病治療実現に向けた共同開発研究を開始しました …
Nov 21, 2019 · 島根大学 竹谷先生と進めてきたRECのプロジェクトが、AMED再生医療実用化研究事業に採択されました！ PuRECでは完治が困難な低ホスファターゼ症に対するREC治療 …See details»
mAbProtein - Overview, News & Competitors | ZoomInfo.com
MAbProtein is a company that operates in the Biotechnology industry. It employs 51-100 people and has $5M-$10M of revenue. The company is headquartered in Izumo, Shimane, Japan.See details»
Driving Innovation in Antibody Development - mabprotein.co.jp
G196, anti-DLVPR tag (G196) mAb (Catalog # R-G-001, lower panel). This gene encodes a member of the interleukin-1 (IL-1) family of cytokines. In addition to its role in the inflammatory …See details»
Driving Innovation in Antibody Development - mabprotein.co.jp
MAb G196/G196-epitope peptide (five amino acid sequence Asp-Leu-Val-Pro-Arg, DLVPR) is a new peptide tagging system for cell biology and biochemistry research. The recognition …See details»
Generation and characterization of antagonistic anti-human …
Mar 15, 2019 · TU is employed by Shimane University and is currently co-founder and Chief Medical & Scientific Officer of mAbProtein, a biotech company focusing on the development …See details»
Generation of the novel anti-FXYD5 monoclonal antibody and its ...
We identified the FXYD5 protein as the target protein of mAb 12-13.8, by a human protein array screening system. The FXYD5 protein is overexpressed in various types of cancer and is …See details»
Monoclonal Antibody Against Mature Interleukin-18 Ameliorates …
Aug 1, 2024 · 4 mAbProtein Co. Ltd., Izumo 693-8501, Japan. Background: Antitumor necrosis factor (TNF)-α antibodies have improved the outcome of inflammatory bowel disease (IBD); …See details»
Understanding and controlling the molecular mechanisms of …
Oct 1, 2023 · In antibody development and manufacturing, protein aggregation is a common challenge that can lead to serious efficacy and safety issues. To mitigate this problem, it is …See details»